| Lynn Marie Evertz, LYNN EVERTZ | |
|
443 W Coulter Ave Unit 6, Powell, WY 82435-2643 | |
| (307) 754-2323 | |
| Not Available |
| Full Name | Lynn Marie Evertz |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 443 W Coulter Ave Unit 6, Powell, Wyoming |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033299821 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 14377 (Wyoming) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lynn Marie Evertz, LYNN EVERTZ 1277 Lane 10, Powell, WY 82435-9323 Ph: (307) 754-2323 | Lynn Marie Evertz, LYNN EVERTZ 443 W Coulter Ave Unit 6, Powell, WY 82435-2643 Ph: (307) 754-2323 |
News Archive
A simple laboratory test to measure protein C - a natural anti-blood-clotting substance that also reflects the level of inflammation in the body - may offer a useful new indicator of the severity of illness and risk of death among critically ill patients.
Amgen today announced that the U.S. Food and Drug Administration (FDA) has granted priority review designation to denosumab, a subcutaneous RANK Ligand inhibitor, for the treatment of bone metastases to reduce skeletal related events (SREs) in patients with cancer.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced two upcoming presentations of preclinical data from the company's VB-111 program at the American Association for Cancer Research 102nd Annual Meeting.
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that the U.S. Food and Drug Administration (FDA) has approved ZORVOLEX™ (diclofenac) capsules, a nonsteroidal anti-inflammatory drug (NSAID), for the treatment of mild to moderate acute pain in adults. ZORVOLEX was approved at dosage strengths that are 20 percent lower than currently available diclofenac products.
› Verified 5 days ago
Brian P O'neill, APRN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 1134 Road 7, Powell, WY 82435 Phone: 307-754-9196 | |
Lexie Hill, DNP, FNP-BC Registered Nurse Medicare: Medicare Enrolled Practice Location: 777 Avenue H, Powell, WY 82435 Phone: 307-754-7257 | |
Brittney Hyland, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 872 Lane 6, Powell, WY 82435 Phone: 307-250-8087 Fax: 866-526-0457 | |
David Hyland, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 210 N Bent St, Powell, WY 82435 Phone: 307-250-8087 Fax: 866-526-0457 | |
Mrs. Karen Jean Nemitz, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 770 E Monroe St, Powell, WY 82435 Phone: 307-754-4783 | |
Mrs. Alisa Mccoy, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 644 Oakwood Dr, Powell, WY 82435 Phone: 307-254-0208 |